Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation

J Clin Psychopharmacol. 2011 Oct;31(5):673-5. doi: 10.1097/JCP.0b013e31822c92d4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Asperger Syndrome / complications
  • Asperger Syndrome / drug therapy*
  • Asperger Syndrome / physiopathology
  • Excitatory Amino Acid Antagonists / adverse effects
  • Excitatory Amino Acid Antagonists / pharmacology
  • Excitatory Amino Acid Antagonists / therapeutic use*
  • Humans
  • Male
  • Memantine / adverse effects
  • Memantine / pharmacology
  • Memantine / therapeutic use*
  • Obsessive-Compulsive Disorder / complications
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / physiopathology
  • Treatment Outcome

Substances

  • Excitatory Amino Acid Antagonists
  • Memantine